Annual Results Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
1.85
24.16
44.57
84.50
81.54
73.00
Shareholder's Funds
1.85
24.16
44.57
84.50
81.54
73.00
Minority Interest
0.00
0.00
22.36
23.46
22.03
20.67
Long-Term Borrowings
19.61
19.62
0.87
2.17
2.23
1.18
Secured Loans
19.61
19.62
0.87
2.17
2.23
1.18
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
15.37
15.48
12.3
17.15
16.19
1.02
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
15.37
34.38
12.30
17.15
16.19
1.02
Current Liabilities
Trade Payables
2.72
4.44
3.29
4.79
3.67
5.11
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
36.45
16.73
17.00
13.19
7.98
7.95
Total Liabilities
53.67
75.27
96.23
138.30
127.73
102.63
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
17.07
16.28
15.53
24.06
12.50
10.80
Less: Accumulated Depreciation
5.71
4.65
2.30
2.24
1.74
1.11
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
11.36
11.63
13.23
21.82
10.76
9.69
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
1.91
1.69
4.40
40.13
29.44
14.04
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.59
0.77
4.12
2.18
0.30
0.50
Total Non-Current Assets
14.10
15.92
22.81
76.33
53.71
41.13
Current Assets Loans & Advances
Current Investments
2.62
13.69
4.22
9.87
9.31
0.62
Inventories
5.25
15.88
6.14
1.91
1.36
4.54
Sundry Debtors
15.35
10.14
12.97
9.80
4.64
1.29
Cash and Bank
13.47
17.08
47.11
38.70
57.06
53.62
Other Current Assets
36.69
56.78
70.45
60.28
72.37
60.08
Short Term Loans and Advances
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Assets
39.58
59.34
73.42
61.97
74.03
61.50
Net Current Assets (Including Current Investments)
3.12
42.62
56.42
48.78
66.05
53.55
Total Current Assets Excluding Current Investments
39.58
59.34
73.42
61.97
74.03
61.50
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
53.67
75.27
96.23
138.30
127.73
102.63
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
19.61
19.62
0.87
2.17
2.23
1.18
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
Compare Balance Sheet Results of CASI Pharmaceuticals, Inc.
Figures in Million
Consolidated - Balance Sheet Results
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
1.85
65.47
-63.62
-97.17%
Shareholder's Funds
1.85
65.47
-63.62
-97.17%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
19.61
0.80
18.81
2,351.25%
Secured Loans
19.61
0.80
18.81
2,351.25%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
15.37
6.88
8.49
123.40%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
15.37
6.88
8.49
123.40%
Current Liabilities
Trade Payables
2.72
5.35
-2.63
-49.16%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
36.45
9.57
26.88
280.88%
Total Liabilities
53.67
81.92
-28.25
-34.48%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
17.07
31.82
-14.75
-46.35%
Less: Accumulated Depreciation
5.71
23.09
-17.38
-75.27%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
11.36
8.72
2.64
30.28%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
1.91
0
1.91
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0.59
0.33
0.26
78.79%
Total Non-Current Assets
14.10
10.12
3.98
39.33%
Current Assets Loans & Advances
Current Investments
2.62
40.89
-38.27
-93.59%
Inventories
5.25
0
5.25
0.00%
Sundry Debtors
15.35
0
15.35
0.00%
Cash and Bank
13.47
27.73
-14.26
-51.42%
Other Current Assets
36.69
68.92
-32.23
-46.76%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
39.58
71.81
-32.23
-44.88%
Net Current Assets (Including Current Investments)
3.12
62.23
-59.11
-94.99%
Total Current Assets Excluding Current Investments
39.58
71.81
-32.23
-44.88%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
53.67
81.92
-28.25
-34.48%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
19.61
0.80
18.81
2,351.25%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Analysis not available as Data has been published for only 1 period
Annual - Investments
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Analysis not available as Data has been published for only 1 period
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
